# An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis

> clinical trial · VERIFIED · 2026-08-21

Status: RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Rheumatoid Arthritis

- Company: Hoffmann-La Roche
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07620392

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.